Antifungal agents are group of drugs commonly prescribed in treatment of fungal infections which are widely spread among global population. Their properties such as absorption, distribution, metabolism, route of elimination or plasma protein binding (PPB), considerably influence their therapeutic success, while number of drug's molecular physicochemical properties notably influence all these processes. Lipophilicity (log P), molecular weight (Mw), volume (Vol), polar surface area (PSA) and solubility (log S) play important roles in drug absorption, penetration into tissues, distribution and route of elimination or the degree of plasma protein binding. In this study, the relationships between these five molecular properties of eight antifungal drugs and their plasma protein binding data obtained from relevant literature were investigated. The drug's selected physicochemical molecular descriptors were calculated using software packages. The relationships between PPB and PSA; Mw; Vol and log S were established showing relatively poor correlation (r<0.35). The best correlation was obtained for the relationship between PPB data and lipophilicity descriptor X log P3 (correlation coefficient r = 0.55). In further investigation, multiple linear regression analysis was applied. The best correlation was obtained with application of lipophilicity with polar surface area (r = 0.918) and volume (r = 0.916) or molecular weight (r = 0.896) as independent variables.
INTRODUCTION
Many drugs bind with human plasma protein. Plasma protein binding (PPB) is the reversible interaction of drugs with the proteins that has great influence to the pharmacokinetic properties and pharmacodynamics properties of a drug. A drug's efficiency may be affected by the degree to which it binds since only a fraction of unbound drug is able to pass across cell membranes and exhibits pharmacological effects. Excessive plasma protein binding decreases concentration of a free and thus active drug form, requiring higher doses to achieve therapeutic *Corresponding author: jodovic@pharmacy.bg.ac.rs; Tel.: +381 11 3951-234; Fax: +381 11 3972-840 https://doi.org/10.2298/JSC190925125O O n L i n e F i r s t concentration. Furthermore, administrating two drugs at the same time can sometimes affect each other's fraction unbound. Thus, estimation of plasma protein binding is an important part of characterization of drugs. Fungal infections are widely spread among global population, with intention to increase as well as to develop resistance to appropriate and applicable drugs. It has been estimated that there are more than 5 million fungal species worldwide; approximately 300 fungal species have been recorded to cause disease in humans 1 . Most fungi are resistant to conventional antimicrobial drugs. In comparison to the number of drugs available to treat bacterial infections, the number of drugs available to treat fungal infections is comparatively small 2 .
Antifungal drugs, also called antimycotic drugs are used to treat fungal infection (superficial and systemic infection). The first antifungal drug, amphotericin B deoxycholate, was introduced in 1958. This drug shows potent, broad-spectrum antifungal activity but is associated with significant renal toxicity and infusion reactions. The first-generation of azole drugs became available in the 1990s and frequently were used as therapeutic alternatives to amphotericin B 2 . The second-generation of azole drugs, including voriconazole, posaconazole, and isavuconazole, were brought to market at the beginning of the 2000s. The major advantage of these agents is the extended spectrum of activity 3 .
Based on their site of action antifungals can be grouped into three classes: azoles, which inhibit the synthesis of ergosterol (the main fungal sterol); polyenes, which interact with fungal membrane sterols physicochemically; and 5-fluorocytosine, which inhibits macromolecular synthesis 4 . Beside the antimycotic spectrum, clinical efficacy of an antifungal drug is related to the plasma protein binding 5 . The activity of drug can be a result of limited penetration of proteinbound drug to the site of infection as well as limited ability of protein-bound drug to bind at the site of activity.
Monika Schafer Korting at al. published that influence of protein binding on azole (itraconazole and ketoconazole) antifungal activity is probably less reduced by albumin than is to be expected from in vitro binding studies 6 . On the other hand, despite a free fraction of 1 % in plasma, terbinafine (an allylamine derivative), rapidly penetrates into brain tissue, but inhibition of Aspergillus is lower in the presence of serum proteins 7 . Reduced bioavailability resulting from binding by serum may at least partly account for the low efficacy of terbinafine in experimental models of systemic infection, in contrast to its high efficacy in infections of the skin, nails and hair 8 .
The relevance of antifungal protein binding has been shown for most of drugs 9 (Table I.) .
As it can be seen the range of serum protein binding ranges from 11 % (fluconazole) to 99 % (itraconazole and terbinafine) 10 . The extent of binding is dependent on the structure and physicochemical properties of the drug molecule. The aim of this study is to establish correlation between protein binding and physicochemical properties of selected antifungal drugs. Selected antifungal drugs are: amphotericine B (polyene antifungals, systemic infections); terbinafine (allylamines, superficial infections); ketoconazole (imidazole derivative, systemic); fluconazole, itraconazole, posaconazole, voriconasole (triazole derivatives, systemic) and caspofungin.
O n L i n e F i r s t
Amphotericin B is a drug of choice for many systemic life-threatening fungal infections. It consists of two distinct regions: hydrophobic and hydrophilic and cannot cross the blood-brain barrier. Amphotericine B is insoluble in water thus several formulations have been invented to improve its intravenous bioavailability.
Terbinafine belongs to a newer allylamine class of antifungals. It is highly liphophillic and is used topically for superficial skin infections as a cream or powder. Terbinafine hydrochloride tablets are used to treat fungal nail and skin infections. In plasma, terbinafine is >99 % bound to plasma proteins and there are no specific binding sites.
Azoles (imidazoles and triazoles) are the largest class of antimycotics. Ketoconazole was the first orally active antifungal. It is slightly soluble in water (pKa 6.5) and more hydrophilic than other derivatives of imidazole (clotrimazole, miconazole). Fluconazole has two triazole rings and hydroxy group which makes it water soluble (log P = 0.31). As a free base fluconazole is suitable for both oral and i.v. administration. Itraconazole is structurally related to ketoconazole and posaconazole is novel itraconazole analog designed after its active ω-1 hydroxy metabolite. Voriconazole is fluconazole analog with additional methyl group and one triazole ring replaced by fluorinated pyrimidine.
Caspofungin is a lipopeptide antifungal drug which belongs to a new class of antifungal agents with broad spectrum of activity against all Candida species.
EXPERIMENTAL
The following antifungal agents were included in investigation: [1, 4, 7, 10, 13 ,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide. Phycochemical properties of selected antifungal drugs were described with 5 selected molecular descriptors: log P (lipophilicity); log S (solubility); PSA (polar surface area, electronic descriptor); Mw (molecular weight, constitutional parameter) and Vol (volume value, geometric descriptor). The log P coefficient is well-known as one of the principal parameters for the estimation of lipophilicity of drugs and determines their pharmacokinetic properties 11 . For selected antifungal compounds seven different lipophilicity parameters: A log Ps, AC log P, mi log P, A log P, M log P, X log P2 and X log P3 were calculated. The most suitable log P value was chosen on the basis of its best matching with values of plasma protein binding degree data which were obtained from relevant literature [12] [13] [14] . Values of log P and log S were calculated using software package Virtual Computational Chemistry Laboratory. PSA, Mw, Vol were calculated using Molinspiration software package 15, 16 .
The calculation of lipophilicity descriptors, different log P values (A log Ps, AC log P, mi log P, A log P, M log P, X log P2, X log P3) were performed using software package Virtual Computational Chemistry Laboratory 16 . The first letters of molecular descriptor mark are related to the method of calculation of lipophilicity. The methods applied can be divided as: substructure-based (atom-based and fragmental methods) and property-based methods. The atom-based methods provide several lipophilicity descriptors (A log P, AC log P, X log P2, X log P3,) in which molecules are cut down to the single atoms and commonly do not apply corrections while fragmental methods cut molecules into fragments with corrections application and summing contributions of all fragment to provide final log P value (mi log P). The property-based methods use the description of the entire molecules and include: empirical methods based on molecule's 3D-structure or methods based on topological descriptors (M log P, A log Ps) [17] [18] [19] . The abbreviations used for descriptors are: A logPs, neural networks is used to predict the log P; AC log P, atom-additive method; mi log P, calculation include charge interactions and organometallic compounds; A log P, classical atomic contribution approach; M log P, Moriguchi octanol-water partition coefficient; X log P2, additive atom/group model and X log P3, based on additive atom/group model which starts from the known log P value of a similarly reference compound 20 . 
O n L i n e F i r s t

RESULTS AND DISCUSSION
The lipophilicity considerably influences drugs' ADME properties namely, absorption, distribution, metabolism and elimination 17, 18 and it is generally known that molecules with high lipophilicity show higher values of plasma protein binding as well as better oral absorption. Consequently, those molecules show better bioavailability, distribution and penetration into tissues, in comparison to the ones with similar properties but less lipophilic characteristics.
Considering these, seven lipophilicity parameters, log P values, for all selected antifungal agents were calculated using Virtual Computational Chemistry Laboratory software package.
These methods, depending on the way of calculation (property-based and substructure-based methods) and differences in-between provide dissimilarities among absolute log P values 19, 20 .
All collected log P and log S values of investigated antifungal agents are shown in Table II . Terbinafine has the highest lipophilicity as well as group of azoles: itraconazole, posaconazole and ketoconazole. The difference in chemical structures of the azoles contribute to different value of log P: itraconasole is aryl-triazolone derivative of ketokonazole with a N-1-branched alkyl group which contribute to lipophilicity; posaconazole is hydroxylated analogues of itracinazole. Amphotericin B, fluconazole and caspofungin show the lowest lipophilicity.
Intercorrelations of different log P values were calculated for seven investigated molecules (caspofungin was not included in intercorrelation since its A log P and M log P values were not available). The obtained results show good agreements, with correlation coefficients mostly higher than 0.7 (Table III) . The best results are observed for X log P3 data. Solubility is molecular property, with important influence on drug's absorption, transport to the blood as well as plasma protein binding degree. Molecules with very low solubility usually exhibit high lipophilicity and these properties can lead to poor oral absorption. Average calculated solubility values (Ave log S) of antifungal agents are ranged from (-6.08) for itraconazole and (-6.09) for posaconazole to (-2.26) for fluconazole and (-3.39) for voriconazole (Table II) .
O n L i n e F i r s t
Fluconazole, bis triazole derivative has the highest solubility (-2.26) which is in accordance with its chemical structure. Its analogue, voriconazole, has fluorine substituted pyrimidine ring instead of one of triazoles which makes it less soluble in comparison with Fluconazole, but still more soluble than the other investigated compounds. Ketoconazole has similar solubility as voriconazole (-3.88 and -3.39 respectively) which can be attributed to four oxygen atoms in its structure, even without two triazole rings. Amfotericin B has long carbohydrate chain indicating its low solubility, but large number of hydroxy groups, as well as free carboxylic group makes it more water soluble (-4.56). Naphtalene ring in terbinafine structure as well as longer carbohydrate chain indicates lower water solubility / higher lipophylicity of this compound. Itraconazole and Posaconazole are the most lipophilic of all examined structures which is obvious from their structure. They have the highest molecular weight and many carbon atoms, and three benzene rings indicate their low water solubility (-6.08 for ketoconazole and -6.09 for posaconazole). It is necessary to emphasize that the water solubility assessment of all the above compounds is not simple. Solubility largely depends on the 3d structure, and not only on the basic structural elements.
Additional molecular properties such as molecular weight, molecular volume and polar surface area (Table IV) From obtained results it can be concluded that the lowest values of PSA (3 Å 2 ) as well as Mw (291 Da) belong to terbinafine while highest values of all three parameters has been obtained for amphotericin B and caspofungin Mw (924 and 1093 Da), PSA (320 and 412 Å 2 ) and Vol (865 and 1026 Å 3 ). The terbinafine already has shown very high value of lipophilicity and low water solubility, while amphotericin B and caspofungin can be pointed as antifungal agent with relatively low lipophilicity and high water solubility.
Plasma protein binding
According to the data obtained from relevant literature, the investigated antifungal agents (amphotericin B, fluconazole, itraconazole, ketoconazole, posaconazole, terbinafine, voriconazole and caspofungin) have high and relatively similar values of plasma protein binding (Table I) . The plasma protein binding degree (PPB, %) can be ranged from 90 % (amphotericin B) to 99.8 % (itraconazole). Ketoconazole, posaconazole, terbinafine and caspofungin have also high and very similar values of PPB: 99, 98, 99 and 97 % respectively. However, fluconazole and voriconazole represent exceptions and they have significantly lower values of plasma protein binding (12 and 58 %, respectively) [12] [13] [14] .
Statistical analysis was performed in order to determine whether there is a relationship between PPB and molecular descriptors. The correlations between PPB, % and antifungal agent's calculated molecular descriptors were investigated using simple linear regression. The relationships between PPB and PSA; Mw; Vol and log S were established showing relatively poor correlation (r < 0.35). The best correlation was obtained for the relationship between PPB data and lipophilicity descriptor X log P3 (correlation coefficient r= 0.55). Therefore, lipophilicity descriptor X log P3 was chosen for further study.
O n L i n e F i r s t
Since there is more than one descriptor that influence PPB, multiple linear regression analysis (MLR) was applied. Multiple regression models has possibility to describe how a single response variable (PPB) depends linearly on a X log P3 values and one additional molecular descriptor: Mw, or Vol, or PSA, or log S.
Obtained correlation coefficients (r) were in the range from 0.896 to 0.918. The lowest correlation coefficient (0.563) was obtained for aqueous solubility data (log S). The best r value was established for electronic descriptor PSA (0.918) and geometric descriptor Vol (0.916).
According Asuero et al. 21 all relationships with obtained correlation coefficients higher than 0.80 can be considered as very good, especially in the case of limited number of compounds (eight investigated antifungal drugs). The best-established correlations using MLR analysis are presented with Equations from (1) All results obtained using MLR analysis (applying two different descriptors as independent variables) are presented in Table V and as well as at Fig. 1 . Intercorrelations between all obtained PPB data of investigated antifungal agents: those collected from relevant literature [12] [13] [14] and predicted using (A) X log P3 and PSA; (B) X log P3 and Vol data (C); X log P3 and Mw and (D) X log P3 and log S, are presented in Table VI. O n L i n e F i r s t Figure 1 . The relationship between antifungal agents PPB, % collected from literature (series 1) and those predicted using X log P3 and PSA (series 2); X log P3 and Vol (series 3); X log P3 and Mw (series 4). The selection criteria for drug-like properties (namely drugs molecular properties responsible for its medical applicability, safety and efficiency) 22 of investigated antifungal drugs' are reported in Table VII . O n L i n e F i r s t CONCLUSION The discovery of new pharmacologically active substances and moddeling of drugs with antifungal activity led to necessity of predicting drugs properties and their ADME data. The relations that were found between antifungal drugs' plasma protein binding data and their calculated molecular descriptors, confirmed that drugs molecular physicochemical properties are essential for drugs plasma protein binding and further for targeting appropriate receptors and drugs activity and medical efficiency. The understanding of investigated drugs molecular physicochemical properties is especially important in design and synthesize of new drugs candidates with optimal ratio between efficiency and side effects.
